Sign inJoin waitlistJoin the waitlist

Ayshe Beesen

Program Director, Neurocritical Care Fellowship · UMass Chan Medical School

Credentials: · · · ·

History

Neurocritical Care Fellowship · UMass Chan Medical School
Present
Neurocritical Care Center · UMass Chan Medical School
Present
UMass Chan Medical School
Present

2015–2016
Neurocritical Care
Cedar Sinai School of Medicine
2013–2015
Neurology
UCLA David Geffen School of Medicine/UCLA Medical Center
2011–2013
Icahn School of Medicine at Mount Sinai
2005–2009

Research

Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice
Journal of Neuroscience · 2003 · 534 citations
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
Journal of Neuroscience · 2013 · 97 citations
Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons
Journal of Neurochemistry · 2009 · 19 citations

AM
Aidan Manning
1 paper
DG
Diana Godfrey
1 paper · 1 as a resident
LL
Laura Liberman
1 paper
Mary Gemignani
1 paper
MA
Michelle Azu
1 paper
Neil Kowall
1 paper
SH
Steven Hersch
1 paper
YK
Yoshio Kaneko
1 paper · 1 as a resident